Patient with cutaneous diphtheria in reception centre This week, a refugee from Syria was found to be infected with the diphtheria bacterium. The patient has been treated with antibiotics. The patient’s contacts have been tested and vaccinated.
National Heatwave Plan no longer in operation as of 17 August 2022 As of Wednesday, 17 August 2022, the National Heatwave Plan is no longer in operation. Although the period of persistent heat is over, temperatures will remain high over the coming days.
National Heatwave Plan to be activated on 10 August After consulting the Royal Netherlands Meteorological Institute (KNMI), RIVM has decided to activate the National Heatwave Plan in all Dutch provinces as of 10 August 2022.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
National Heatwave Plan no longer in effect, smog alert withdrawn As of Thursday, 21 July 2022, the National Heatwave Plan is no longer in effect. RIVM also withdraws the smog alert.
Smog alert in the Netherlands Tuesday 19 July Just as in recent days, today 19 July there is a risk of smog across the Netherlands due to high ozone concentrations.
National Heatwave Plan active as of 18 July and smog warning throughout the Netherlands It is warm and the heat will continue over the coming days. For many people, this means enjoying the beach or garden. For others, heat can be less enjoyable.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.